Abstract
Ambulant patients with recently diagnosed generalised or psychomotor seizure disorders or both were randomly assigned to two dosage regimens of phenytoin. Drug compliance was evaluated with subsequent blood phenytoin levels four to eight weeks after initial enrollment into the study. Although the two groups had similar mg-kg daily dosages of phenytoin, the mean blood levels were statistically different between the two groups, favoring the simplified dosage regimen. Once or twice a day dosage regimens of phenytoin had a beneficial effect on drug compliance when compared to more frequent regimens as measured by phenytoin blood levels.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abraham C. V., Joslin H. D. Simultaneous gas-chromatographic analysis for phenobarbital, diphenylhydantoin, carbamazepine, and primidone in serum. Clin Chem. 1976 Jun;22(6):769–771. [PubMed] [Google Scholar]
- Boyd J. R., Covington T. R., Stanaszek W. F., Coussons R. T. Drug defaulting. I. Determinants of compliance. Am J Hosp Pharm. 1974 Apr;31(4):362–367. [PubMed] [Google Scholar]
- Buchanan R. A., Allen R. J. Diphenylhydantoin (Dilatin) and phenobarbital blood levels in epileptic children. Neurology. 1971 Aug;21(8):866–871. doi: 10.1212/wnl.21.8.866. [DOI] [PubMed] [Google Scholar]
- Buchanan R. A., Kinkel A. W., Goulet J. R., Smith T. C. The metabolism of diphenylhydantoin (Dilantin) following once-daily administration. Neurology. 1972 Feb;22(2):126–130. doi: 10.1212/wnl.22.2.126. [DOI] [PubMed] [Google Scholar]
- Gibberd F. B., Dunne J. F., Handley A. J., Hazleman B. L. Supervision of epileptic patients taking phenytoin. Br Med J. 1970 Jan 17;1(5689):147–149. doi: 10.1136/bmj.1.5689.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haerer A. F., Buchanan R. A. Effectiveness of single daily doses of diphenylhydantoin. Neurology. 1972 Oct;22(10):1021–1025. doi: 10.1212/wnl.22.9.1021. [DOI] [PubMed] [Google Scholar]
- Haerer A. F., Grace J. B. Studies of anticonvulsant levels in epileptics. I. Serum diphenylhydantoin concentrations in a group of medically indigent outpatients. Acta Neurol Scand. 1969;45(1):18–31. [PubMed] [Google Scholar]
- Kutt H., Haynes J., McDowell F. Some causes of ineffectiveness of diphenylhydantoin. Arch Neurol. 1966 May;14(5):489–492. doi: 10.1001/archneur.1966.00470110033004. [DOI] [PubMed] [Google Scholar]
- LUND M., JORGENSEN R. S., KUEHL V. SERUM DIPHENYLHYDANTOIN (PHENYTOIN) IN AMBULANT PATIENTS WITH EPILEPSY. Epilepsia. 1964 Mar;5:51–58. doi: 10.1111/j.1528-1157.1964.tb04345.x. [DOI] [PubMed] [Google Scholar]
- Lascelles P. T., Kocen R. S., Reynolds E. H. The distribution of plasma phenytoin levels in epileptic patients. J Neurol Neurosurg Psychiatry. 1970 Aug;33(4):501–505. doi: 10.1136/jnnp.33.4.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lund L. Anticonvulsant effect of diphenylhydantoin relative to plasma levels. A prospective three-year study in ambulant patients with generalized epileptic seizures. Arch Neurol. 1974 Nov;31(5):289–294. doi: 10.1001/archneur.1974.00490410037002. [DOI] [PubMed] [Google Scholar]
- Mushlin A. I., Appel F. A. Diagnosing potential noncompliance. Physicians' ability in a behavioral dimension of medical care. Arch Intern Med. 1977 Mar;137(3):318–321. doi: 10.1001/archinte.137.3.318. [DOI] [PubMed] [Google Scholar]
- Porter A. M. Drug defaulting in a general practice. Br Med J. 1969 Jan 25;1(5638):218–222. doi: 10.1136/bmj.1.5638.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Richens A. A study of the pharmacokinetics of phenytoin (diphenylhydantoin) in epileptic patients, and the development of a nomogram for making dose increments. Epilepsia. 1975 Nov;16(4):627–646. doi: 10.1111/j.1528-1157.1975.tb04745.x. [DOI] [PubMed] [Google Scholar]